You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low grade Lymphoma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

Completed
  • Serous Ovarian Carcinoma
  • Low Grade Serous Ovarian Carcinoma
  • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
  • Lyon, France
    Hospices civils de Lyon
Feb 14, 2023

HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)

Recruiting
  • HPV-Related Cervical Carcinoma
  • +3 more
  • CO2
  • Wenzhou, Zhejiang, China
    first affiliated hospital of Wenzhou medical university
Sep 23, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 9, 2022

Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

Recruiting
  • Low-Grade Glioma
  • +2 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 24, 2022

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

Follicular Lymphoma Trial in Australia (Opdivo)

Active, not recruiting
  • Follicular Lymphoma
  • Ballarat, Victoria, Australia
  • +4 more
Jan 30, 2023

Degenerative Lumbar Spondylolisthesis Trial in Luxembourg (NVDX3)

Not yet recruiting
  • Degenerative Lumbar Spondylolisthesis
  • Luxembourg, Luxembourg
    Centre Hospitalier de Luxembourg
Jul 18, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)

Recruiting
  • Indolent Lymphoma
  • Low-dose Radiotherapy
  • Low-dose radiotherapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 13, 2022

Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

Active, not recruiting
  • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
  • +11 more
  • Washington, District of Columbia
  • +6 more
Feb 2, 2023

Low-grade Glioma Trial (Tovorafenib)

Available
  • Low-grade Glioma
  • (no location specified)
Feb 23, 2023

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

B-cell Lymphoma Trial in United States (SD-101, Radiation therapy)

Terminated
Has Results
  • B-cell Lymphoma
  • Stanford, California
  • +4 more
Aug 20, 2020

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)

Not yet recruiting
  • Lymphoma
  • Ultra Low Dose 4 Gy Radiation
  • (no location specified)
Jun 30, 2023

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Low Dose Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

Available
  • Large B-cell Lymphoma
  • +4 more
  • Epcoritamab
  • (no location specified)
Feb 16, 2023

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • PI3K inhibitor BKM120
  • +3 more
  • Atlanta, Georgia
  • +1 more
Jun 27, 2022

Barretts Esophagus With Dysplasia, Barrett Esophagus, Esophageal Adenocarcinoma Trial in Aurora (Endoscopic Eradication Therapy)

Recruiting
  • Barretts Esophagus With Dysplasia
  • +2 more
  • Endoscopic Eradication Therapy
  • Aurora, Colorado
    University of Colorado
Feb 22, 2023

Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Tumors Trial in Frankfurt (Adriamycin, Cyclophosphamide, Cytarabine)

Completed
  • Burkitt's Lymphoma
  • +4 more
  • Frankfurt, Germany
    University Hospital, Medical Dept. II
Aug 17, 2022

Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

Recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +5 more
  • Fresno, California
  • +2 more
Jan 24, 2023